See also this year's filing and all EDGAR filings for this company.
PDF Report 0001322505_2017_Albireo_Pharma_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001322505, Albireo Pharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 30,861,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 18,260,000 |
| 2 | PropertyPlantAndEquipmentNet | 21,000 |
| 3 | remainder_Assets | 518,000 |
| 4 | LiabilitiesCurrent | 12,708,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 14,372,491 |
| 9 | ResearchAndDevelopmentExpense | 8,482,241 |
| 10 | remainder_Expenses | -126,027 |
| 11 | remainder_Revenues | 56,708,996 |
| 12 | remainder_NetIncome | -2,277,834 |
| 13 | remainder_ComprehensiveNetIncome | 692,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 49,660,000 |
| 1 | Liabilities | 12,708,000 |
| 2 | Expenses | 22,728,705 |
| 3 | Revenues | 56,708,996 |
| 4 | StockholdersEquity | 36,952,000 |
| 5 | NetIncome | 31,702,457 |
| 6 | ComprehensiveNetIncome | 32,048,457 |
| 7 | BaseVar | 72,387,768 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.61 |
| 9 | EconomicCapitalRatio | 4.11 |